Transparency in Billing Act of 2023

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety from Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 6833, Continuing Appropriations Act of 2023 HR 9747, Continuing Appropriations and Extensions Act, 2025 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support Reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower Costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 HR 7635 The 340B Pharmaceutical Access to Invest in Essential, Needed Treatments & Support Act of 2024 HR 8574 340B Affording Care for Communities and Ensuring a Strong Safety-net Act HR 8260, Hospital Inpatient Services Modernization Act S 2768, Hospital Inpatient Services Modernization Act HR 10545 American Relief Act of 2025 S 2372 Accelerating Kids Access to Care Act HR 4758 Accelerating Kids Access to Care Act CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Discuss Medicare and Medicaid issues with HHS staff. Discuss with Congressional staff and HHS staff support for Medicare GME expansion and changes to GME program: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act (H.R. 7050); additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855); concerns on Rural Physician Workforce Preservation Act; Senate Finance Committee proposals to increase GME slots. Discussion with CMS on the interpretation of CAA, 2021, Sec. 131, and resetting of GME caps pertaining to Sec. 131. Discuss technical amendment to CAA, 2021, Sec. 131 pertaining to Medicare GME with Congressional staff. Discuss with Congressional staff distribution methodology for Medicare GME slots created in the CAA, 2021. Discuss expiring COVID-19 Public Health Emergency (PHE) Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver (H.R. 7623). Support extension of Medicare Dependent Hospital and Low-Volume Adjustment programs. Support proposals to reduce payment cut in CY 2025 Physician Fee Schedule final rule. Discuss opposition to Medicare site-neutral payment policies with Congressional staff. Oppose changes to NPIs for hospital outpatient departments (H.R. 7623, H.R. 4509, H.R. 7623 as amended, H.R. 4822). Comment on FY 2024 IPPS rule to increase payment update to hospitals, Transforming Episodic Accountability Model, AHEAD Model, and CAA, 2023 Sec 4122 GME slot distribution methodology, and discuss comments with Congressional staff and CMS staff. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Support certain changes to Medicaid DSH payments: support two-year elimination of Medicaid DSH cut scheduled for January 1, 2025; support Save Our Safety Net Hospitals Act (H.R. 9351) to restore pre-CAA, 2021 DSH cap calculation methodology and include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver. Discuss Medicaid IMD exclusion policies with Congressional staff. Support legislation to increase Medicaid payment rates for labor and delivery services for certain hospitals (S.5236). Discuss with Congressional staff support for CMS approval of Medicaid managed care organization tax proposed in New York State budget. Oppose CMS final rule to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities (89 FR 40876) and support legislative efforts to repeal rule. Support Medicare Advantage prior authorization reforms - Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702). Meet with CMS staff and CMS Regional Administrator to discuss Medicare Advantage (MA) plans and MA utilization management practices. Discuss wage index issues with Congressional staff: H.R. 8561 to address MA local area growth under projection, FY 2025 IPPS/LTCH interim final rule, indirect medical education (IME) payments to hospitals. Meet with CMS Innovation Center to discuss CMMI models of care. Meet with CMS leadership to discuss Medicare and Medicaid issues: prior authorization and MA insurance denials, concerns on mandatory participation for AHEAD and TEAM models, Medicare support for health care workforce; support for telehealth flexibilities and Acute Hospital Care at Home waiver extension.

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss opposition to Medicare site-neutral payment policies with Congressional staff. Educate Congressional staff on hospital price transparency federal rule (84 FR 65602). Oppose changes to NPIs for hospital outpatient departments (H.R. 7623, H.R. 4509, H.R. 7623 as amended, H.R. 4822). Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier (NPI) requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Discuss hospital and health provisions in CAA, 2024 (H.R. 4366) with HHS staff and Congressional staff: support public health extenders and elimination of Medicaid DSH cut. Discuss support for the 340B Drug Pricing Program with Congressional staff and discuss certain changes: oppose 340B ACCESS Act (H.R. 7635), comment on SUSTAIN 340B Act discussion draft, support PATIENTS Act (H.R. 7635); oppose back-end rebate proposals. Discuss legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff. Discuss with Congressional staff support for Medicare GME expansion and changes to GME program: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act (H.R. 7050); additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855); concerns on Rural Physician Workforce Preservation Act and opposition to modifications to ongoing slot distribution; Senate Finance Committee draft proposals to increase GME slots. Discuss with HHS staff and Congressional staff recommendations to address workforce shortages for nursing and ancillary health care workforce: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S.2768). Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME: S.665/H.R.4942, S.2719/H.R.6980, H.R. 4875. Discuss expiring COVID-19 Public Health Emergency Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver: H.R. 7623. Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards (S.5218). Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff. Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff. Support Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702). Discuss legislative proposals on consumer medical debt with Congressional staff. Outreach to HHS Assistant Secretary for Preparedness and Response urging certain regulatory flexibilities to alleviate IV fluid shortages.

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act; H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025; H.R. 10545, American Relief Act, 2025.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act; H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025; H.R. 10545, American Relief Act, 2025.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- H.R. 5378, "Lower Costs, More Transparency Act" - ERISA preemption - S. 1869, the Site-based Invoicing and Transparency Enhancement Act ("SITE Act") - H.R. 4509, Transparency in Billing Act - Issues related to employer-sponsored health benefits and health coverage - Taxation of health benefits - Anti-tiering and Anti-steering clauses - Transparency - Cost containment - S. 1001, HR 1843: Telehealth Expansion Act of 2023 - S. 655, Chronic Disease Management Act of 2023 - Site-neutral payments - Value-based payments - H.R. 3800, the Chronic Disease Flexible Coverage Act

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act--extending enhanced APTCs (H.R. 9774) and unauthorized enrollments in Marketplace plans (S. 4767), Affordability (H.R. 3589), Behavioral Health, Health Equity, Maternal Health, Surprise Billing, Health IT, Cybersecurity, Interoperability, Value-Based Care, Health Care Innovation, Telehealth-extending flexibilities, Transparency & PBMs (S. 127, S. 1339, S. 3430, H.R. 3651, H.R. 4507, H.R. 4508, H.R. 4509, H.R. 4527, H.R. 4822, H.R. 5378), Provider Directories (S. 3430, Sec. 109), Prescription Drugs (S. 150, S. 1067, S. 1114, S. 2305)

Client expense: $660,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 6833, Continuing Appropriations Act of 2023 HR 9747, Continuing Appropriations and Extensions Act, 2025 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 HR 7635 The 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2024 HR 8574 340B Affording Care for Communities and Ensuring a Strong Safety-net Act HR 8260, Hospital Inpatient Services Modernization Act S 2768, Hospital Inpatient Services Modernization Act CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $45,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 6833, Continuing Appropriations Act of 2023 HR 9747, Continuing Appropriations and Extensions Act, 2025 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 HR 7635 The 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2024 HR 8574 340B Affording Care for Communities and Ensuring a Strong Safety-net Act HR 8260, Hospital Inpatient Services Modernization Act S 2768, Hospital Inpatient Services Modernization Act CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $45,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss support for the 340B Drug Pricing Program with Congressional staff and discuss certain changes: oppose 340B ACCESS Act (H.R. 7635), comment on SUSTAIN 340B Act discussion draft, support PATIENTS Act (H.R. 7635). Discuss legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff. Discuss with Congressional staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act (H.R. 7050); additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act (H.R. 7855). Oppose Rural Physician Workforce Preservation Act (H.R. 8235) and modifications to ongoing distribution of CAA, 2021 Section 126 GME slots. Discuss with HHS staff and Congressional staff recommendations to address workforce shortages for nursing and ancillary health care workforce with Congressional staff: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act (H.R. 2584/S.2768). Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME: S.665/H.R.4942, S.2719/H.R.6980, H.R. 4875. Meet with Congressional staff to discuss technical amendment to CAA, 2021, Section 131. Respond to Senate Finance Committee request for information on Medicare GME and offer recommendations. Discuss opposition to site-neutral payment policies with Congressional staff. Educate Congressional staff on hospital price transparency federal rule (84 FR 65602). Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier (NPI) requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, Medicare sequester cuts, and NPI proposals in H.R. 4822. Oppose changes to NPIs for hospital outpatient departments (H.R. 7623, H.R. 4509, H.R. 7623 as amended). Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments. Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff. Discuss hospital and health provisions in CAA, 2024 (H.R. 4366) with HHS staff. Discuss expiring COVID-19 Public Health Emergency Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to extend PHE telehealth flexibilities and Acute Hospital Care at Home Waiver: H.R. 7623. Support public health extenders and elimination of Medicaid DSH cut in CAA, 2024 (H.R. 4366). Meet with Congressional staff to discuss proposals for financial relief for hospitals affected by the Change Healthcare cyberattack. Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards (S.5218). Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff. Support S.5026, SEPSIS Act. Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff. Discuss FDA final rule to regulate laboratory developed tests (89 FR 37286) with Congressional staff. Support passage of Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702). Discuss legislative proposals on consumer medical debt with Congressional staff. Discuss life safety building code requirements with HHS.

Client expense: $830,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

- H.R. 5378, "Lower Costs, More Transparency Act" - ERISA preemption - S. 1869, the Site-based Invoicing and Transparency Enhancement Act ("SITE Act") - H.R. 4509, Transparency in Billing Act - Issues related to employer-sponsored health benefits and health coverage - Taxation of health benefits - Anti-tiering and Anti-steering clauses - Transparency - Cost containment - S. 1001, HR 1843: Telehealth Expansion Act of 2023 - S. 655, Chronic Disease Management Act of 2023 - Site-neutral payments - Value-based payments

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act (extending enhanced APTCs, unauthorized enrollments in Marketplace plans), Affordability, Behavioral Health, Health Equity, Maternal Health, Surprise Billing, Health IT, Cybersecurity, Interoperability, Value-Based Care, Health Care Innovation, Telehealth-extending flexibilities, Transparency & PBMs (S. 127, S. 1339, S. 3430, H.R. 3651, H.R. 4507, H.R. 4508, H.R. 4509, H.R. 4527, H.R. 4822, H.R. 5378), Provider Directories (S. 3430, Sec. 109), Insulin Affordability (S. 1269, S. 954), Prescription Drugs (S. 150, S. 1067, S. 1114, S. 2305)

Client expense: $650,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss support for the 340B Drug Pricing Program with Congressional staff and oppose certain changes. Respond to Senate request for information on 340B Drug Pricing Program - SUSTAIN 340B Act discussion draft. Oppose 340B ACCESS Act (H.R. 7635). Discuss legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff. Discuss with Congressional staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act; additional GME slots in CAA, 2021 and CAA, 2023. Support the Rural Residency Planning and Development Act (H.R. 7855) to provide grant funding for rural hospitals seeking to develop GME programs. Oppose Rural Physician Workforce Preservation Act (H.R. 8235) and modifications to ongoing distribution of CAA, 2021 Section 126 GME slots. Discuss with Congressional staff legislative recommendations to address workforce shortages for nursing and ancillary health care workforce with Congressional staff: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act to create legal penalties for individuals who assault or intimidate hospital employees. Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME: S.665/H.R.4942, S.2719/H.R.6980, H.R. 4875. Meet with Congressional staff to discuss technical amendment to CAA, 2021 Section 131. Respond to Senate Finance Committee request for information on Medicare GME and offer recommendations. Discuss federal support for nursing and allied health workforce with HHS staff. Discuss opposition to site-neutral payment policies with Congressional staff. Educate Congressional staff on hospital price transparency federal rule (84 FR 65602). Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Oppose changes to national provider identifier requirements in H.R. 7623. Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments. Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff. Discuss hospital and health provisions in CAA, 2024 (H.R. 4366) with HHS staff. Discuss telehealth issues with Congressional staff and support legislative proposals to extend PHE telehealth flexibilities. Support legislative proposals for additional extension of the Acute Hospital Care at Home waiver. Support public health extenders and elimination of Medicaid DSH cut in CAA, 2024 (H.R. 4366) and discuss with Congressional staff. Meet with Congressional staff to discuss proposals for financial relief for hospitals affected by the Change Healthcare cyberattack. Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards. Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff. Discuss federal legislative proposals for sepsis reporting with Congressional staff. Discuss Earned Income Tax Credit and opposition to ERTC proposal in the Tax Relief for American Families and Workers Act of 2024 with Congressional staff. Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff. Discuss FDA final rule to regulate laboratory developed tests (89 FR 37286) with Congressional staff. Support passage of Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702).

Client expense: $370,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 HR 7635 The 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2024 HR 8574 340B Affording Care for Communities and Ensuring a Strong Safety-net Act CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 HR 7635 The 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support Act of 2024 HR 8574 340B Affording Care for Communities and Ensuring a Strong Safety-net Act CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $4,803,802 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

- H.R. 5378, "Lower Costs, More Transparency Act" - ERISA preemption - S. 1869, the Site-based Invoicing and Transparency Enhancement Act ("SITE Act") - H.R. 4509, Transparency in Billing Act - Issues related to employer-sponsored health benefits and health coverage - Taxation of health benefits - Anti-tiering and Anti-steering clauses - Transparency - Cost containment - S. 1001, HR 1843: Telehealth Expansion Act of 2023 - S. 655, Chronic Disease Management Act of 2023 - Site-neutral payments - Value-based payments

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Meet with Congressional staff and discuss support for Medicare graduate medical education (GME) funding, including support for the Resident Physician Shortage Reduction Act, the Opioid Workforce Act, Substance Use Disorder Workforce Act, the Pathway to Practice program proposal, and the Presidents FY 2025 budget request. Discuss Medicare and Medicaid issues with HHS staff. Oppose CMS proposed rule CMS-4332-P to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities. Support delay of Medicaid DSH cut and advocate for two-year elimination of Medicaid DSH cut. Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss telehealth issues with Congressional staff and support for the permanent extension of COVID-19 PHE telehealth flexibilities. Discuss Acute Hospital Care at Home waiver and support for extension. Discuss legislation to provide financial support for safety net hospitals. Discuss issues concerning DSH hospitals with the Executive Branch. Meet with CMS Innovation Center to discuss CMMI models of care. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss opposition of site-neutral payment policies with Congressional staff. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss Making Care Primary model with CMMI staff. Discuss Medicaid waiver application with CMS staff. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver application. Meet with CMS staff regarding Medicare managed care. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Discuss Medicaid IMD exclusion policies with Congressional staff. Discuss with Congressional staff support for revisions to FY 2024 IPPS proposed rule to increase payment update to hospitals. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Discussion with congressional staff regarding Medicare Disproportionate Share Hospital (DSH) rulemaking. Discussion with CMS on the interpretation of Sec. 131 in the Consolidated Appropriations Act, 2021, and resetting of GME caps pertaining to Sec. 131 in the Consolidated Appropriations Act, 2021. Discuss technical amendment to Consolidated Appropriations Act, 2021 Sec. 131 pertaining to Medicare GME with Congressional staff. Discuss CMS requirement to report telehealth provider home addresses with HHS staff. Meet with CMS to discuss Inpatient Prospective Payment Systems (IPPS) policies and Medicare payments. Support elimination of Medicaid DSH cut in Consolidated Appropriations Act, 2024 (H.R. 4366). Meet with CMS Regional Administrator to discuss the behavioral health care workforce. Meet with CMS staff and CMS Regional Administrator to discuss Medicare Advantage (MA) plans and MA utilization management practices. Meet with CMS to discuss 340B remedy final rule. Meet with CMS to discuss hospital price transparency regulations. Brief Congressional staff on GME for foreign medical graduates. Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME.

Client expense: $340,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss support for the 340B Drug Pricing Program with Congressional staff and oppose certain changes. Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss opposition to site-neutral payment policies with Congressional staff. Discuss hospital and health care provisions included in the Consolidated Appropriations Act of 2023 with Congressional staff. Discuss the following legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities. Support additional extension of the Acute Hospital Care at Home waiver. Educate Congressional staff on hospital price transparency federal rule (84 FR 65602). Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss Medicare Graduate Medical Education (GME) provisions in the Consolidated Appropriations Act (CAA), 2021 and CAA, 2023 with HHS staff. Discuss with Congressional staff support for Medicare GME expansion: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act; additional GME slots in CAA, 2021 and CAA, 2023. Discuss legislative recommendations from Senate HELP Committee RFI response letter on workforce shortages for nursing and ancillary health care workforce with Congressional staff: faculty recruitment and retention, additional financial support for supervision and precepting students, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Discuss Making Care Primary model with CMMI staff. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Discuss community benefit standard and tax-exempt status of non-profit hospitals with Congressional staff. Respond to Senate RFI on 340B Drug Pricing Program - SUSTAIN 340B Act discussion draft. Discuss opposition to FDA Proposed Rulemaking on Laboratory Developed Tests (88 FR 68006) with Congressional staff. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose National Provider Identifier requirements for hospital outpatient departments, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies for drug administration services, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments. Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff. Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff. Discuss Further Continuing Appropriations and Other Extensions Act, 2024 (H.R. 6363); Continuing Appropriations Act, 2024 and Other Extensions Act (H.R. 5860); and Extension of Continuing Appropriations and Other Matters Act, 2024 (H.R. 7463) with Congressional staff and express support for funding extensions for: Community Health Centers, Teaching Health Center Graduate Medical Education funding, National Health Service Corps; support delay of Medicaid DSH cut in H.R. 6363, H.R. 5860, and H.R. 7463. Support public health extenders and elimination of Medicaid DSH cut in Consolidated Appropriations Act, 2024 (H.R. 4366). Meet with CMS staff to discuss behavioral health coverage for commercial insurers. Discussion with CMS Regional Administrator and Regional Health Coordinator on opioid access, 340B final rule, and Medicare Advantage utilization management practices. Meet with Congressional staff to discuss technical amendment to Section 131 of the Consolidated Appropriations Act of 2021. Meet with Congressional staff to discuss proposals for financial relief for hospitals affected by the Change Healthcare cyberattack. Discuss federal legislative proposals for sepsis reporting with Congressional staff. Discuss Earned Income Tax Credit and opposition to ERTC proposal in the Tax Relief for American Families and Workers Act of 2024 with Congressional staff. Discuss military graduate medical education (GME) with Congressional staff. Support passage of the Safety from Violence for Healthcare Employees (SAVE) Act to create legal penalties for individuals who assault or intimidate hospital employees. Oppose legislative proposals to impose financial penalties on hospitals relating to minimum cybersecurity standards. Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff.

Client expense: $340,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act, Affordability, Behavioral Health, Health Equity, Maternal Health, Surprise Billing, Health IT, Interoperability, Value-Based Care, Health Care Innovation, COVID-19 Commercialization, Telehealth-extending flexibilities, Transparency & PBMs (S. 127, S. 1339, S. 3430, H.R. 3651, H.R. 4507, H.R. 4508, H.R. 4509, H.R. 4527, H.R. 4822, H.R. 5378), Provider Directories, Insulin Affordability (S. 1269, S. 954), Prescription Drugs (S. 150, S. 1067, S. 1114, S. 2305)

Client expense: $600,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits S.113 - Prescription Pricing for the People Act S.127 - Pharmacy Benefit Manager Transparency Act S.142 - Preserve Access to Affordable Generics and Biosimilars Act S.148 - Stop STALLING Act S.150 - Affordable Prescriptions for Patients Act S.652 - Safe Step Act S.655 - Chronic Disease Management Act S.727 - Insulin for All Act S.775 - Increasing Transparency in Generic Drug Applications Act S.954 - Affordable Insulin Now Act S.1038 - Drug Price Transparency in Medicaid Act S.1067 - Ensuring Timely Access to Generics Act S.1114 - Expanding Access to Low-Cost Generics Act S.1120 - Improved Access to Affordable Medications Act S.1128 - Ensuring Access to Generic Medications Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1218 - Fair Prescription Drug Prices for Americans Act S.1269 - INSULIN Act S.1339 - Pharmacy Benefit Manager Reform Act S.1375 - HELP Copays Act S.1497 - Emergency Access to Insulin Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1542 - Delinking Revenue from Unfair Gouging (DRUG) Act S.1543 - A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third party administration services S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2666 - EPCS 2.0 Act S.2840 - Bipartisan Primary Care and Health Workforce Act (Bruan Amendment #3 - Price Transparency Requirements) S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1488 - Affordable Insulin Now Act H.R.1587 - Making Insulin Affordable for All Children Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.1790 - Biologics Competition Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3030 - Stop the Overuse of Petitions and Get Affordable Medicines to Enter Soon (STOP GAMES) Act H.R.3134 - Emergency Access to Insulin Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.3800 - Chronic Disease Flexible Coverage Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4507 - Transparency in Coverage Act H.R.4508 - Hidden Fee Disclosure Act H.R.4509 - Transparency in Billing Act H.R.4527 - Health Data Act H.R.4712 - Patient Right to Shop Act H.R.4822 - Health Care Price Transparency Act H.R.4846 - To amend the Internal Revenue Code of 1986, title XXVII of the Public Health Service Act, and the Employee Retirement Income Security Act of 1974 to provide for oversight of pharmacy benefit manager services H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393 -Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Client expense: $5,294,628 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Affordable Care Act, Affordability, Behavioral Health, Health Equity, Maternal Health, Surprise Billing, Health IT, Interoperability, Value-Based Care, Health Care Innovation, COVID-19 Commercialization, Telehealth-extending flexibilities, Transparency & PBMs (S. 127, S. 1339, H.R. 3651, H.R. 4507, H.R. 4508, H.R. 4509, H.R. 4527, H.R. 4822, H.R. 5378), Provider Directories, Insulin Affordability (S. 1269, S. 954), Prescription Drugs (S. 6, S. 150, S. 1067, S. 1114, S. 2305)

Client expense: $620,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 2665, The Supporting Safety Net Hospitals Act HR 2584, Safety From Violence for Healthcare Employees (Save) Act S 923, Better Mental Health Care for Americans Act HR 3046, Medical Student Education Authorization Act S 1133, the 340B Accountability Act of 2023 HR 3746, Fiscal Responsibility Act of 2023 HR 3290, Transparency and Oversight of the 340B Drug Discount Program Act HR 3841, To reauthorize the program of payments to children's hospitals that operate graduate medical education programs HR 3887, The Children's Hospital GME Support reauthorization Act of 2023 HR 4509 The Transparency in Billing Act HR 4507 The Transparency in Coverage Act of 2023 HR 4527 The Health DATA Act HR 4508 Hidden Fees Disclosure Act HR 4822 The Health Care Price Transparency Act of 2023 HR 1613 The Drug Transparency Act S 1038 The Drug Transparency Act HR 3561 The Patient Act HR 2534 Protect 340B Act of 2023 HR 3226 The PREEMIE Act of 2023 S 1573 The PREEMIE Act of 2023 HR 5378 The Lower costs, More Transparency Act HR 6664 Innovation in Pediatric Drugs Act of 2023 CDC Injury Control Research Centers Funding NIH Pediatric Medical Research Prioritization FDA Proposed Rule Titles "Medical Device Laboratory Developed Tests"

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

- H.R. 5378, "Lower Costs, More Transparency Act" - ERISA preemption - S. 1869, the Site-based Invoicing and Transparency Enhancement Act ("SITE Act") - H.R. 4509, Transparency in Billing Act - Issues related to employer-sponsored health benefits and health coverage - Taxation of health benefits - Anti-tiering and Anti-steering clauses - Transparency - Cost containment - S. 1001, HR 1843: Telehealth Expansion Act of 2023 - S. 655, Chronic Disease Management Act of 2023 - Site-neutral payments - Value-based payments

Client expense: Not reported · Firm income: $160,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 3801 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). H.R. 3797 (Paperwork Burden Reduction Act): This bill modifies provisions under the Patient Protection and Affordable Care Act so that employers and health insurance providers are no longer required to send tax forms to covered individuals showing proof of minimum essential coverage (1095-B and 1095-C tax forms) unless a form is requested. S. 3204 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). S. 3207 (Paperwork Burden Reduction Act): This bill modifies provisions under the Patient Protection and Affordable Care Act so that employers and health insurance providers are no longer required to send tax forms to covered individuals showing proof of minimum essential coverage (1095-B and 1095-C tax forms) unless a form is requested. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 3561 (The PATIENT Act of 2023): This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. H.R. 5138 (Improving Access to Medicare Coverage Act of 2023): To amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital stay requirement for coverage of skilled nursing facility services under Medicare, and for other purposes. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. .R. 1843 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S. 1001 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. H.R. 4509 (Transparency in Billing Act): To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 1264 (Commonsense Reporting Act): This bill addresses the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy under the Patient Protection and Affordable Care Act.

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 3801 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). H.R. 3797 (Paperwork Burden Reduction Act): This bill modifies provisions under the Patient Protection and Affordable Care Act so that employers and health insurance providers are no longer required to send tax forms to covered individuals showing proof of minimum essential coverage (1095-B and 1095-C tax forms) unless a form is requested. S. 3204 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). S. 3207 (Paperwork Burden Reduction Act): This bill modifies provisions under the Patient Protection and Affordable Care Act so that employers and health insurance providers are no longer required to send tax forms to covered individuals showing proof of minimum essential coverage (1095-B and 1095-C tax forms) unless a form is requested. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 3561 (The PATIENT Act of 2023): This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. H.R.5138 (Improving Access to Medicare Coverage Act of 2023): To amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital stay requirement for coverage of skilled nursing facility services under Medicare, and for other purposes. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 3801 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). H.R. 3561 (The PATIENT Act of 2023): This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. H.R. 1843 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S. 1001 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. H.R. 4509 (Transparency in Billing Act): To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 1264 (Commonsense Reporting Act): This bill addresses the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy under the Patient Protection and Affordable Care Act.

Client expense: $330,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office

H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 3801 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). H.R. 3797 (Paperwork Burden Reduction Act): This bill modifies provisions under the Patient Protection and Affordable Care Act so that employers and health insurance providers are no longer required to send tax forms to covered individuals showing proof of minimum essential coverage (1095-B and 1095-C tax forms) unless a form is requested. S. 3204 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). S. 3207 (Paperwork Burden Reduction Act): This bill modifies provisions under the Patient Protection and Affordable Care Act so that employers and health insurance providers are no longer required to send tax forms to covered individuals showing proof of minimum essential coverage (1095-B and 1095-C tax forms) unless a form is requested. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 3561 (The PATIENT Act of 2023): This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. H.R.5138 (Improving Access to Medicare Coverage Act of 2023): To amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital stay requirement for coverage of skilled nursing facility services under Medicare, and for other purposes. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 3801 (Employer Reporting Improvement Act): This bill modifies provisions under the ACA that require employers and health insurance providers to prepare tax forms showing proof of minimum essential coverage (1095-B and 1095-C tax forms). H.R. 3561 (The PATIENT Act of 2023): This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. H.R. 1843 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S. 1001 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. H.R. 4509 (Transparency in Billing Act): To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 1264 (Commonsense Reporting Act): This bill addresses the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy under the Patient Protection and Affordable Care Act.

Client expense: $330,000 · Firm income: Not reported

Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, White House Office

H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 5138 (Improving Access to Medicare Coverage Act of 2023): To amend title XVIII of the Social Security Act to count a period of receipt of outpatient observation services in a hospital toward satisfying the 3-day inpatient hospital stay requirement for coverage of skilled nursing facility services under Medicare, and for other purposes. H.R. 5688 (Bipartisan HSA Improvement Act of 2023): A bill to amend the Internal Revenue Code of 1986 to improve health savings accounts. H.R. 5687 (The HSA Modernization Act of 2023): A bill to amend the Internal Revenue Code of 1986 to modernize health savings accounts. H.R. 5378 (Lower Costs, More Transparency Act): A bill to promote price transparency in the health care sector, and for other purposes. H.R. 3561 (The PATIENT Act of 2023): This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. .R. 1843 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. S. 1001 (Telehealth Expansion Act of 2023): To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules. H.R. 4509 (Transparency in Billing Act): To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes.

Client expense: $330,000 · Firm income: Not reported

Government targets: Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislative and regulatory policy proposals to protect employer-sponsored health care coverage; S. 655, Chronic Disease Management Act; S. 1001 / H.R. 1843, Telehealth Expansion Act of 2023; S. 731, TELEHEALTH HSA Act of 2023; H.R. 3800 / S. 3224, the Chronic Disease Flexible Coverage Act; H.R. 3237, to amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department; H.R. 3417, the FAIR Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023; H.R. 4509, the Transparency in Billing Act; S. 1869, the Site-based Invoicing and Transparency Enhancement Act; S. 1451 / H.R. 3120, the Healthy Competition for Better Care Act; H.R. 5378, the Lower Costs, More Transparency Act; S. 2840, the Bipartisan Primary Care and Health Workforce Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Meet with Congressional staff and discuss support for Medicare graduate medical education funding, including support for the Resident Physician Shortage Reduction Act, the Opioid Workforce Act, Substance Use Disorder Workforce Act, the Pathway to Practice program proposal, and the Presidents FY 2024 budget request. Advocate for the inclusion of Medicare GME funding in FY 2024 federal budget. Meet with HHS Region II to discuss GME legislation - the Resident Physician Shortage Reduction Act. Discuss Medicare and Medicaid issues with HHS Assistant Secretary for Legislation. Oppose CMS proposed rule CMS-4332-P to establish minimum nurse staffing in Medicare- and Medicaid-certified long-term care facilities. Support delay of Medicaid DSH cut and advocate for passage of legislation to delay Medicaid DSH Cut (H.R. 2665, Supporting Safety Net Hospitals Act). Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss Medicaid waiver proposal with Congressional staff and HHS. Discuss telehealth issues with Congressional staff and support for the permanent extension of PHE telehealth flexibilities. Discuss Acute Hospital Care at Home waiver and support for its permanent extension. Discuss legislation to provide support for safety net hospitals. Discuss issues concerning DSH hospitals with the Executive Branch. Meet with CMS Innovation Center to discuss CMMI models of care. Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss opposition of site-neutral payment policies with Congressional staff. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities: removing Medicare geographic and originating site restrictions, expanding the list of practitioners eligible to furnish telehealth services, extending telehealth services for federally qualified health centers and rural health clinics, delaying in-person Medicare requirements related to behavioral health care, and allowing audio-only services. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss Making Care Primary model with CMMI staff. Discuss Medicaid waiver application with CMS staff. Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver application. Meet with CMS staff regarding Medicare managed care. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Express opposition to Medicaid work requirements in Limit, Save, Grow Act of 2023 to Congressional staff. Discuss Medicaid IMD exclusion policies with Congressional staff. Discuss with Congressional staff support for revisions to FY 2024 IPPS proposed rule to increase payment update to hospitals. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Discussion with congressional staff regarding Medicare Disproportionate Share Hospital (DSH) rulemaking. Support two-year elimination of Medicaid DSH cut and express support for elimination to Congressional staff. Discussion with CMS on the interpretation of Sec. 131 in the Consolidated Appropriations Act, 2021, and resetting of GME caps pertaining to Sec. 131 in the Consolidated Appropriations Act, 2021. Discuss technical amendment to Consolidated Appropriations Act, 2021 Sec. 131 pertaining to Medicare GME with Congressional staff. Discuss CMS requirement to report telehealth provider home addresses with HHS staff. Discuss health care workforce and graduate medical education funding with HHS Assistant Secretary for Legislation. Meet with CMS to discuss Inpatient Prospective Payment Systems (IPPS) policies and Medicare payments.

Client expense: $910,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Support revisions to Medicaid DSH policy to include dual-eligible patients in state DSH cap calculation. Discuss support for the 340B Drug Pricing Program with Congressional staff and oppose changes. Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff. Discuss opposition to site-neutral payment policies with Congressional staff. Discuss FEMA reimbursement for Employee Support Costs and Hazard Pay with FEMA. Discuss FEMA reimbursement for Employee Support Costs and Hazard Pay with Congressional staff. Discuss hospital and health care provisions included in the Consolidated Appropriations Act of 2023 with Congressional staff. Discuss the following legislative proposals with Congressional staff to stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support); make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities. Discuss nursing and ancillary health care staff shortages and support reforms: faculty recruitment and retention, additional financial support for supervision and precepting students, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training site, and immigration reforms that expedite entry for foreign health care workers. Discuss telehealth issues with Congressional staff and support the permanent extension of PHE telehealth flexibilities: removing Medicare geographic and originating site restrictions, expanding the list of practitioners eligible to furnish telehealth services, extending telehealth services for federally qualified health centers and rural health clinics, delaying in-person Medicare requirements related to behavioral health care, and allowing audio-only services. Support the permanent extension of the Acute Hospital Care at Home waiver. Support Medicare Advantage prior authorization reforms and pass Improving Seniors Timely Access to Care Act (support). Discuss the Resident Physician Shortage Reduction Act with Congressional staff. Discuss the Pathway to Practice Act of 2021 with Congressional staff. Discuss commercial insurance issues and health care workforce shortages with Senate Health, Education, Labor, and Pensions (HELP) Committee. Discuss GME provisions in the Consolidated Appropriations Act of 2023 with HHS staff. Educate Congressional staff on hospital price transparency federal rule. Respond to Senate HELP Committee Request for Information (RFI) on workforce shortages and supply legislative recommendations. Discuss legislative recommendations from Senate HELP Committee RFI response letter on workforce shortages with Senate Finance Committee staff. Discuss Making Care Primary model with CMMI staff. Discuss Medicare payment for nursing and allied health with Senate Finance Committee staff. Discuss end of PHE billing with HHS Health Insurance Administrator. Discuss PATIENT Act (HR 3561) with Congressional staff, including: price transparency proposal, opposition to site-neutral policies for drug administration, opposition to attestation requirements for hospital billing, opposition to changes to Inpatient Only List, support for Medicare Advantage reporting requirements, opposition to changes to 340B program, support for Community Health Center and health care workforce reauthorizations. Discuss community benefit standard and tax-exempt status of non-profit hospitals with Congressional staff. Respond to Senate RFI on 340B Drug Pricing Program. Discuss 340B remedy proposed rule with Congressional staff. Discuss opposition to FDA Proposed Rulemaking on Laboratory Developed Tests with Congressional staff. Discuss HHS Climate Pledge and Inflation Reduction Act funding with HHS staff. Meet with Senate staff to discuss requests for health care workforce investments in FY 2024 Labor-HHS-Ed appropriations legislation. Meet with Congressional staff to discuss H.R. 5378, the Lower Costs, More Transparency Act of 2023, and comment on following proposals in bill: support for delay of Medicaid DSH cut, codification and expansion of Federal price transparency rule, oppose changes to 340B drug pricing program, support reauthorization of Community Health Centers, support reauthorization of National Health Service Corps, support reauthorization of Teaching Health Center Graduate Medical Education funding. Oppose Medicare site-neutral cuts, sequester cuts, and national provider identifier proposals in H.R. 4822, the Health Care Price Transparency Act of 2023. Oppose H.R. 4509 to require a separate unique health identifier for hospital outpatient departments. Discuss H.R. 3561, the PATIENT Act, with Congressional staff and comment on following proposals within bill: opposition to Medicare site-neutral policies for drug administration services, opposition to attestation requirements for hospital outpatient departments, opposition to changes to 340B drug pricing program, support for delay of Medicaid DSH cuts, support for Medicare Advantage plan reporting requirements, support for Community Health Center Fund and National Health Service Corps reauthorization. Comment on legislative proposals in S.2840, the Primary Care and Health Workforce Expansion Act: oppose eliminating facility fees, oppose requiring a separate identification number for off-campus hospital outpatient departments. Discuss S.3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, with Congressional staff. Discuss Continuing Appropriations Act, 2024 and Other Extensions Act (H.R. 5860) with Congressional staff and express support for funding extensions for: Community Health Centers, Teaching Health Center Graduate Medical Education funding, National Health Service Corps; support delay of Medicaid DSH cut. Discuss Further Continuing Appropriations and Other Extensions Act, 2024 (H.R. 6363) with Congressional staff and express support for funding extensions for: Community Health Centers, Teaching Health Center Graduate Medical Education funding, National Health Service Corps; support delay of Medicaid DSH cut. Discuss legislative proposals to regulate the use of artificial intelligence in health care delivery with Congressional staff.

Client expense: $910,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Individual Market Prior Authorization Mental Health and Substance Use, Behavioral Health Crisis Intervention and 9-8-8 hotline services Mental Health Parity Fair Hospital Billing and Claims Form Issues Facilitating Accountability in Reimbursements Act (FAIR Act) (H.R. 3417) Site-based Invoicing and Transparency Enhancement (SITE) Act (S.1869) Mental Health Workforce Act (H.R. 3760) Transparency in Billing Act (H.R. 4509) Transparency in Coverage Act (H.R. 4507) Health Data Act (H.R. 4527) Hidden Fee Disclosure Act (H.R. 4508) The Health Care Price Transparency Act of 2023 (H.R. 4822) PATIENT Act (H.R. 3561) Lower Cost, More Transparency Act (H.R. 5378) Primary Care and Workforce Act (S. 2840) BCBSA of Louisiana Acquisition AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Health - Veterans Community Care program Military OneSource program

Client expense: $1,250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Individual Market Prior Authorization Mental Health and Substance Use, Behavioral Health Crisis Intervention and 9-8-8 hotline services Mental Health Parity Fair Hospital Billing and Claims Form Issues Facilitating Accountability in Reimbursements Act (FAIR Act) (H.R. 3417) Site-based Invoicing and Transparency Enhancement (SITE) Act (S.1869) Mental Health Workforce Act (H.R. 3760) Transparency in Billing Act (H.R. 4509) Transparency in Coverage Act (H.R. 4507) Health Data Act (H.R. 4527) Hidden Fee Disclosure Act (H.R. 4508) The Health Care Price Transparency Act of 2023 (H.R. 4822) PATIENT Act (H.R. 3561) Lower Cost, More Transparency Act (H.R. 5378) Primary Care and Workforce Act (S. 2840) BCBSA of Louisiana Acquisition AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Health - Veterans Community Care program Military OneSource program

Client expense: $1,250,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Individual Market Prior Authorization Mental Health and Substance Use, Behavioral Health Crisis Intervention and 9-8-8 hotline services Mental Health Parity Fair Hospital Billing and Claims Form Issues Facilitating Accountability in Reimbursements Act (FAIR Act) (H.R. 3417) Site-based Invoicing and Transparency Enhancement (SITE) Act (S.1869) Mental Health Workforce Act (H.R. 3760) Transparency in Billing Act (H.R. 4509) Transparency in Coverage Act (H.R. 4507) Health Data Act (H.R. 4527) Hidden Fee Disclosure Act (H.R. 4508) The Health Care Price Transparency Act of 2023 (H.R. 4822) PATIENT Act (H.R. 3561) Lower Cost, More Transparency Act (H.R. 5378) Primary Care and Workforce Act (S. 2840) BCBSA of Louisiana Acquisition AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Health - Veterans Community Care program Military OneSource program

Client expense: $1,230,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Individual Market Prior Authorization Mental Health and Substance Use, Behavioral Health Crisis Intervention and 9-8-8 hotline services Mental Health Parity Fair Hospital Billing and Claims Form Issues Facilitating Accountability in Reimbursements Act (FAIR Act) (H.R. 3417) Site-based Invoicing and Transparency Enhancement (SITE) Act (S.1869) Mental Health Workforce Act (H.R. 3760) Transparency in Billing Act (H.R. 4509) Transparency in Coverage Act (H.R. 4507) Health Data Act (H.R. 4527) Hidden Fee Disclosure Act (H.R. 4508) The Health Care Price Transparency Act of 2023 (H.R. 4822) PATIENT Act (H.R. 3561) Lower Cost, More Transparency Act (H.R. 5378) Primary Care and Workforce Act (S. 2840) BCBSA of Louisiana Acquisition AI Use in Healthcare Health Disparities, including Maternal Health and Rural Health Veterans Health - Veterans Community Care program Military OneSource program

Client expense: $1,230,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office